BMC pharmacology & toxicology
eISSN: 2050-6511pISSN: 2050-6511
Open AccessShare this on:
Key Metrics
CiteScore 
4
SJR
Q3Pharmacology
Topics Covered
Oxidative stress
Acne
Nitric oxide
Rosuvastatin
Catalase
Survival rate
Acetaminophen
Bioavailability
Emergency department
Type 2 diabetes
Confidence interval
AKT1
MTT assay
Blood pressure
Doxorubicin
Carnosine
Atorvastatin
Plumbagin
Anthraquinone
Superoxide dismutase
Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
Web of Science
Overview
- PublisherSpringer Nature
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesGBP 1690 | USD 2590
- Publication Time12
- Editorial Review ProcessOpen peer review
General Details
- LanguageEnglish
- FrequencyContinuous publication
- Publication Start Year2001
- Publisher URL
- Website URL
Publication Details
- Plagiarism
- Publication Time12
- Waiver Policy
Editorial Review Detail
- Editorial Team
- Review ProcessOpen peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC0
- OA statement
View less
Planning to publish in BMC pharmacology & toxicology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers
Coenzyme Q 10 protected against arsenite and enhanced the capacity of 2,3-dimercaptosuccinic acid to ameliorate arsenite-induced toxicity in mice
- 7 Apr 2021
- BMC Pharmacology and Toxicology
BMC Pharmacology and Toxicology reviewer acknowledgement 2015
- 17 Feb 2016
- BMC Pharmacology and Toxicology
BMC Pharmacology and Toxicology reviewer acknowledgement 2014
- 12 May 2015
- BMC Pharmacology and Toxicology
Abstract not submitted for publication
- 1 Aug 2013
- BMC Pharmacology and Toxicology
The role of PGE 2 EP 4 receptors in the regulation of endothelial barrier function
- 17 Sep 2012
- BMC Pharmacology and Toxicology
Coenzyme Q 10 protected against arsenite and enhanced the capacity of 2,3-dimercaptosuccinic acid to ameliorate arsenite-induced toxicity in mice
- 7 Apr 2021
- BMC Pharmacology and Toxicology
BMC Pharmacology and Toxicology reviewer acknowledgement 2015
- 17 Feb 2016
- BMC Pharmacology and Toxicology
BMC Pharmacology and Toxicology reviewer acknowledgement 2014
- 12 May 2015
- BMC Pharmacology and Toxicology
Abstract not submitted for publication
- 1 Aug 2013
- BMC Pharmacology and Toxicology
The role of PGE 2 EP 4 receptors in the regulation of endothelial barrier function
- 17 Sep 2012
- BMC Pharmacology and Toxicology
FAQs
How long has BMC pharmacology & toxicology been actively publishing? 
BMC pharmacology & toxicology has been in operation since 2001 till date.
What is the publishing frequency of BMC pharmacology & toxicology?
BMC pharmacology & toxicology published with a Continuous publication frequency.
How many articles did BMC pharmacology & toxicology publish last year?
In 2022, BMC pharmacology & toxicology publsihed undefined articles.
What is the eISSN & pISSN for BMC pharmacology & toxicology?
For BMC pharmacology & toxicology, eISSN is 2050-6511 and pISSN is 2050-6511.
What is Citescore for BMC pharmacology & toxicology?
Citescore for BMC pharmacology & toxicology is 4.
What is the SJR for BMC pharmacology & toxicology?
SJR for BMC pharmacology & toxicology is Q3.
Who is the publisher of BMC pharmacology & toxicology?
Springer Nature is the publisher of BMC pharmacology & toxicology.